No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs573987450 |
chr14:20687052-20687053 |
Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs571416091 |
chr14:20687059-20687060 |
Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs78068126 |
chr14:20687107-20687108 |
Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs115138842 |
chr14:20687132-20687133 |
Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs115656238 |
chr14:20687134-20687135 |
Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs567040881 |
chr14:20687176-20687177 |
Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs545593556 |
chr14:20687261-20687262 |
Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs555648073 |
chr14:20687262-20687263 |
Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs563982747 |
chr14:20687267-20687268 |
Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs190557726 |
chr14:20687294-20687295 |
Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs541255030 |
chr14:20687350-20687351 |
Enhancers Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs538018294 |
chr14:20687419-20687420 |
Flanking Active TSS Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs78353735 |
chr14:20687477-20687478 |
Flanking Active TSS Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs2318889 |
chr14:20687506-20687507 |
Flanking Active TSS Enhancers
|
TF binding region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
15 |
rs114760764 |
chr14:20687517-20687518 |
Flanking Active TSS Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs544957647 |
chr14:20687521-20687522 |
Flanking Active TSS Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs76639655 |
chr14:20687585-20687586 |
Flanking Active TSS Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs2873832 |
chr14:20687586-20687587 |
Flanking Active TSS Enhancers
|
TF binding region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
19 |
rs181073708 |
chr14:20687603-20687604 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs372190051 |
chr14:20687604-20687605 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs375511533 |
chr14:20687619-20687620 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs4569165 |
chr14:20687628-20687629 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
23 |
rs185281290 |
chr14:20687646-20687647 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs546860245 |
chr14:20687658-20687659 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs10149766 |
chr14:20687666-20687667 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
26 |
rs112186906 |
chr14:20687706-20687707 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs550568082 |
chr14:20687715-20687716 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs370858021 |
chr14:20687752-20687753 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs117800771 |
chr14:20687770-20687771 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs542846133 |
chr14:20687786-20687787 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs535904171 |
chr14:20687787-20687788 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs78922110 |
chr14:20687788-20687789 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs556003073 |
chr14:20687789-20687790 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs113241362 |
chr14:20687791-20687792 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs574298187 |
chr14:20687792-20687793 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs60893732 |
chr14:20687862-20687863 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs534336087 |
chr14:20687914-20687915 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs533499545 |
chr14:20687921-20687922 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs369138269 |
chr14:20687945-20687946 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs8014956 |
chr14:20687978-20687979 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
41 |
rs377342507 |
chr14:20687981-20687982 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs545119830 |
chr14:20688017-20688018 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs189691521 |
chr14:20688035-20688036 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs573671643 |
chr14:20688074-20688075 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs146967649 |
chr14:20688079-20688080 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs8015147 |
chr14:20688109-20688110 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
47 |
rs139202135 |
chr14:20688121-20688122 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs545149596 |
chr14:20688132-20688133 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs542823743 |
chr14:20688135-20688136 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs528405559 |
chr14:20688203-20688204 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|